Newly Agenda for Biosimilars Europe 2016 to Feature Talks from Merck and Boehringer Ingelheim

LONDON - May 9, 2016 - PRLog -- Registration is now live to attend Biosimilars Europe set to take place this autumn in London, UK.

Widely recognized as one of the most profitable areas of drug development, the global biosimilars market is expected to grow at a CAGR of 40.3% by 2020.* With a raising demand for cost effective biosimilar drugs, Biosimilars Europe 2016 returns for its 7th annual show to showcase the latest updates in regulation, patent expiries and tactical approaches to market entry through informed guidance delivered by a top panel of speakers such as Merck Group, Boehringer Ingelheim GmbH, Bristows LLC and medical agencies from across Europe.

Agenda Highlights Include:

1. Insight into future projections presented in an opening keynote by industry specialist, Dr          Duncan Emerton, FirstWord.
2. 1st hand experience on strategy and portfolio management in a VUCA (Volatile, Uncertain,          Complex & Ambiguous) world through a case study on emerging biosimilars, presented by          Merck Group.
3. Case study updates into both USA and UK litigation with Bristows LLP.
4. Guidance into entering emerging markets with insight into current guidelines, regulation, and         pricing & reimbursement strategies, from Shanghai CP Guojian Pharmaceuticals.
5. A spotlight session on commercialisation featuring talks from RJW & Partners and Abzena.
6. A spotlight session on cutting edge technological developments with progressive outlook into       bioanalytical analysis, yielding 3D structure of monoclonal antibodies, and opportunities for          biosimilars in medical device components.

THE NOTABLE SPEAKER LINE-UP WILL INCLUDE:

•          Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co Ltd
•          Dr Niraj Chhaya, Risk Management, Boehringer Ingelheim GmbH
•          Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group
•          Dr Alok Sharma, Head, Bio-Analytical Development, Lupin Ltd
•          Dr Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety
•          Joan O'Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority, Ireland

The full speaker line-up and detailed agenda are available online at http://www.smi-online.co.uk/pharmaceuticals/uk/biosimilar...

Now in its 7^th year, the well-established conference series has received positive feedback from the industry such as:

"Really wide range of topics" - Kantar Health
"Rich in information and quality speakers" - Globyz Pharma
"Great discussions, networking and education" - Apobiologix
"Interesting mix of scientists, legal and commercial folk" - Allergan
"Impressive - beat my expectations" - Teva

Registration is now open at http://www.smi-online.co.uk/pharmaceuticals/uk/biosimilars-europe?utm_medium=www.biosimilars-europe.com&utm_source=P-184&utm_campaign=pr1

Biosimilars Europe 2016
Conference: 29th & 30th Sept 2016 | Interactive Workshops: 28th Sept 2016
Holiday Inn Kensington Forum, London UK
Proudly Sponsored by: Abzena

--- end ---

*Source: http://www.mordorintelligence.com/industry-reports/global-biosimilars-market-industry?gclid=CjwKEAjw9Zu5BRCS_OuVibujhQ0SJAD7t4Krqr2AMb7UQxQSr7jOCBff4f7PeMsVdymNYoMd9t4TbhoC9YLw_wcB

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk